| Jennifer Lynn Nash, MD | |
|
430 Altair Pkwy Ste 210, Westerville, OH 43082-7647 | |
| (614) 898-7546 | |
| (614) 794-4294 |
| Full Name | Jennifer Lynn Nash |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 27 Years |
| Location | 430 Altair Pkwy Ste 210, Westerville, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518924299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | L8449 (Texas) | Secondary |
| 207N00000X | Dermatology | 35-078847 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Ohio Skin And Cancer Inc | 4688608870 | 10 |
News Archive
Medical technology developer Atomo Diagnostics and market leading diagnostic company BBI Solutions have entered into an agreement to commercialise Atomo's award winning, integrated rapid blood test platform, AtomoRapid.
Federal researchers have discovered that severe stress or trauma early in life could actually change how the brain responds to stress hormones, essentially "re-wiring" the brain for later neuropathological disorders, according to a study, "A role for corticotrophin releasing factor signaling in the lateral habenula and its modulation by early life stress," published in Science Signaling, March 6.
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a randomized Phase 2 study of its lead candidate, CRLX101, in patients with extensive-stage small cell lung cancer (SCLC) sensitive to first-line platinum-based chemotherapy.
Dendreon Corporation announced today the publication of data from the pivotal Phase 3 IMPACT study in the New England Journal of Medicine, showing that PROVENGE (sipuleucel-T) demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomatic metastatic castration resistant prostate cancer. The manuscript is published in the July 29, 2010 issue of the journal.
› Verified 2 days ago
| Entity Name | Central Ohio Skin & Cancer Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922016864 PECOS PAC ID: 4688608870 Enrollment ID: O20050927000501 |
News Archive
Medical technology developer Atomo Diagnostics and market leading diagnostic company BBI Solutions have entered into an agreement to commercialise Atomo's award winning, integrated rapid blood test platform, AtomoRapid.
Federal researchers have discovered that severe stress or trauma early in life could actually change how the brain responds to stress hormones, essentially "re-wiring" the brain for later neuropathological disorders, according to a study, "A role for corticotrophin releasing factor signaling in the lateral habenula and its modulation by early life stress," published in Science Signaling, March 6.
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a randomized Phase 2 study of its lead candidate, CRLX101, in patients with extensive-stage small cell lung cancer (SCLC) sensitive to first-line platinum-based chemotherapy.
Dendreon Corporation announced today the publication of data from the pivotal Phase 3 IMPACT study in the New England Journal of Medicine, showing that PROVENGE (sipuleucel-T) demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomatic metastatic castration resistant prostate cancer. The manuscript is published in the July 29, 2010 issue of the journal.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Lynn Nash, MD 430 Altair Pkwy Ste 210, Westerville, OH 43082-7647 Ph: (614) 898-7546 | Jennifer Lynn Nash, MD 430 Altair Pkwy Ste 210, Westerville, OH 43082-7647 Ph: (614) 898-7546 |
News Archive
Medical technology developer Atomo Diagnostics and market leading diagnostic company BBI Solutions have entered into an agreement to commercialise Atomo's award winning, integrated rapid blood test platform, AtomoRapid.
Federal researchers have discovered that severe stress or trauma early in life could actually change how the brain responds to stress hormones, essentially "re-wiring" the brain for later neuropathological disorders, according to a study, "A role for corticotrophin releasing factor signaling in the lateral habenula and its modulation by early life stress," published in Science Signaling, March 6.
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a randomized Phase 2 study of its lead candidate, CRLX101, in patients with extensive-stage small cell lung cancer (SCLC) sensitive to first-line platinum-based chemotherapy.
Dendreon Corporation announced today the publication of data from the pivotal Phase 3 IMPACT study in the New England Journal of Medicine, showing that PROVENGE (sipuleucel-T) demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomatic metastatic castration resistant prostate cancer. The manuscript is published in the July 29, 2010 issue of the journal.
› Verified 2 days ago
Dr. Joshua A Grosshandler, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 235 W Schrock Rd, Westerville, OH 43081 Phone: 614-895-0400 | |
James W Finn, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 660 Cooper Rd, Ste 400, Westerville, OH 43081 Phone: 614-898-7546 Fax: 614-794-4294 | |
Cory Pettit, Dermatology Medicare: Medicare Enrolled Practice Location: 430 Altair Pkwy Ste 210, Westerville, OH 43082 Phone: 614-898-7546 | |
Rosina P Lin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 235 W Schrock Rd, Westerville, OH 43081 Phone: 614-895-0400 Fax: 614-895-2911 | |
Jess J Demaria, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 430 Altair Pkwy, Ste 210, Westerville, OH 43082 Phone: 614-898-7546 Fax: 614-794-4294 | |
Dr. Thomas Richard Wenker, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 430 Altair Pkwy, Ste 210, Westerville, OH 43082 Phone: 614-898-7546 Fax: 614-794-4294 | |
Linda S Rupert, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 428 County Line Road, Westerville, OH 43082 Phone: 614-847-4100 Fax: 614-430-1601 |